FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052432399> ?p ?o ?g. }

• W2052432399 endingPage "e100981" @default.
• W2052432399 startingPage "e100981" @default.
• W2052432399 abstract "Respiratory syncytial virus (RSV) circulates year round in Taiwan. A novel six consecutive monthly doses of palivizumab for RSV prevention protocol has been approved for high risk preterm infants since December 2010. This study aimed to determine the clinical effectiveness and safety of this novel protocol for the prevention of RSV infection.From April 2011 to March 2013, we enrolled infants born at ≤28 weeks gestation and infants born at ≤35 weeks gestation with chronic lung disease (CLD) who received palivizumab prophylaxis as study group and followed up for 12 months. Historic control, those who were born and followed up between July 2000 and June 2008, were retrieved for propensity score matching. Primary endpoint was RSV-related hospitalization, and secondary endpoints included the length of hospital stay and intensive care unit (ICU) care.We enrolled 127 infants (108 infants born at ≤28 weeks and 19 infants born at 29-35 weeks with CLD). They completed 6-dose palivizumab as scheduled. Among the study group, the RSV-related hospitalizations were 2 (1.6%) within 6 months and 5 (3.9%) within 12 months after discharge. We matched 127 infants in the control group with 127 infants in the study group by propensity score matching. The reduction of RSV-related hospitalization rates were 86% (10.2% vs 1.6%, p = 0.002) within 6 months after discharge and 78% (15.7% vs 3.9%, p = 0.004) within 12 months after discharge. Compared to the control group, the rate of ICU care significantly decreased from 7.1% to 0.8% (p = 0.024) within 6 months after discharge and from 7.9% to 0.8% (p = 0.014) within 12 months after discharge. Adverse events were recorded in 6.4% injections.Six monthly intramuscular administration of palivizumab is effective for prevention of RSV hospitalization in regions with no single seasonal peak of RSV infection such as Taiwan." @default.
• W2052432399 created "2016-06-24" @default.
• W2052432399 creator A5003980800 @default.
• W2052432399 creator A5010126194 @default.
• W2052432399 creator A5021772202 @default.
• W2052432399 creator A5021966402 @default.
• W2052432399 creator A5050302807 @default.
• W2052432399 creator A5050338278 @default.
• W2052432399 creator A5062601525 @default.
• W2052432399 creator A5072656839 @default.
• W2052432399 creator A5077487067 @default.
• W2052432399 creator A5077885226 @default.
• W2052432399 creator A5083101645 @default.
• W2052432399 date "2014-06-27" @default.
• W2052432399 modified "2023-09-26" @default.
• W2052432399 title "A Novel Six Consecutive Monthly Doses of Palivizumab Prophylaxis Protocol for the Prevention of Respiratory Syncytial Virus Infection in High-Risk Preterm Infants in Taiwan" @default.
• W2052432399 cites W1969079131 @default.
• W2052432399 cites W1979032749 @default.
• W2052432399 cites W1985254566 @default.
• W2052432399 cites W1986189079 @default.
• W2052432399 cites W1986328492 @default.
• W2052432399 cites W1988676847 @default.
• W2052432399 cites W1989443539 @default.
• W2052432399 cites W1990546259 @default.
• W2052432399 cites W1994149977 @default.
• W2052432399 cites W1996111042 @default.
• W2052432399 cites W2001093521 @default.
• W2052432399 cites W2013632019 @default.
• W2052432399 cites W2019706667 @default.
• W2052432399 cites W2035305268 @default.
• W2052432399 cites W2035414819 @default.
• W2052432399 cites W2044486890 @default.
• W2052432399 cites W2045859487 @default.
• W2052432399 cites W2048484118 @default.
• W2052432399 cites W2058207519 @default.
• W2052432399 cites W2067738939 @default.
• W2052432399 cites W2077290707 @default.
• W2052432399 cites W2088641860 @default.
• W2052432399 cites W2091101020 @default.
• W2052432399 cites W2098749611 @default.
• W2052432399 cites W2102598551 @default.
• W2052432399 cites W2108488933 @default.
• W2052432399 cites W2113998054 @default.
• W2052432399 cites W2119332183 @default.
• W2052432399 cites W2137511411 @default.
• W2052432399 cites W2148962587 @default.
• W2052432399 cites W2153305701 @default.
• W2052432399 cites W2162334332 @default.
• W2052432399 cites W2320421839 @default.
• W2052432399 cites W2321336000 @default.
• W2052432399 cites W2517356996 @default.
• W2052432399 cites W4255267202 @default.
• W2052432399 cites W4255934323 @default.
• W2052432399 cites W4292315834 @default.
• W2052432399 doi "https://doi.org/10.1371/journal.pone.0100981" @default.
• W2052432399 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4074126" @default.
• W2052432399 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24971565" @default.
• W2052432399 hasPublicationYear "2014" @default.
• W2052432399 type Work @default.
• W2052432399 sameAs 2052432399 @default.
• W2052432399 citedByCount "18" @default.
• W2052432399 countsByYear W20524323992014 @default.
• W2052432399 countsByYear W20524323992015 @default.
• W2052432399 countsByYear W20524323992016 @default.
• W2052432399 countsByYear W20524323992017 @default.
• W2052432399 countsByYear W20524323992018 @default.
• W2052432399 countsByYear W20524323992019 @default.
• W2052432399 countsByYear W20524323992020 @default.
• W2052432399 countsByYear W20524323992021 @default.
• W2052432399 countsByYear W20524323992022 @default.
• W2052432399 countsByYear W20524323992023 @default.
• W2052432399 crossrefType "journal-article" @default.
• W2052432399 hasAuthorship W2052432399A5003980800 @default.
• W2052432399 hasAuthorship W2052432399A5010126194 @default.
• W2052432399 hasAuthorship W2052432399A5021772202 @default.
• W2052432399 hasAuthorship W2052432399A5021966402 @default.
• W2052432399 hasAuthorship W2052432399A5050302807 @default.
• W2052432399 hasAuthorship W2052432399A5050338278 @default.
• W2052432399 hasAuthorship W2052432399A5062601525 @default.
• W2052432399 hasAuthorship W2052432399A5072656839 @default.
• W2052432399 hasAuthorship W2052432399A5077487067 @default.
• W2052432399 hasAuthorship W2052432399A5077885226 @default.
• W2052432399 hasAuthorship W2052432399A5083101645 @default.
• W2052432399 hasBestOaLocation W20524323991 @default.
• W2052432399 hasConcept C126322002 @default.
• W2052432399 hasConcept C168563851 @default.
• W2052432399 hasConcept C17923572 @default.
• W2052432399 hasConcept C187212893 @default.
• W2052432399 hasConcept C203014093 @default.
• W2052432399 hasConcept C203092338 @default.
• W2052432399 hasConcept C2776939746 @default.
• W2052432399 hasConcept C2776983459 @default.
• W2052432399 hasConcept C2777091541 @default.
• W2052432399 hasConcept C2778644256 @default.
• W2052432399 hasConcept C2779234561 @default.
• W2052432399 hasConcept C2779496540 @default.
• W2052432399 hasConcept C3013748606 @default.
• W2052432399 hasConcept C46973012 @default.

• next